|
Signal transduction regulating tumor cell dissemination
|
5R01CA150344-30
|
$396,625
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Designing Novel Anti-Cancer Therapeutics: Targeting Methionine Metabolism
|
5F30CA210372-02
|
$49,524
|
|
FIRESTONE, ROSS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
$142,182
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-04S1
|
$39,254
|
$12,954
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-04
|
$612,939
|
$202,270
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Dietary Combination For Prevention of Metastatic Renal Cell Carcinoma
|
5R01CA176691-05
|
$341,059
|
|
LOKESHWAR, VINATA
|
AUGUSTA UNIVERSITY
|
|
Novel therapeutics for targeting checkpoint dysfunction in cancer
|
5R01CA203824-02
|
$362,569
|
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
THE ROLE OF TELOMERASE REGULATORS IN TELOMERE MAINTENANCE AND GENOMIC INSTABILITY
|
5R01CA211653-02
|
$362,569
|
|
SONGYANG, ZHOU
|
BAYLOR COLLEGE OF MEDICINE
|
|
MiRNAs in hepatocellular carcinoma development and treatment
|
5R01CA139158-07
|
$410,875
|
|
HUANG, WENDONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeted activation of autoimmune checkpoints in B cell malignancies
|
5R01CA157644-09
|
$410,875
|
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention
|
5R01CA164019-06
|
$146,146
|
|
YEE, LISA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Development of selective Pin1 inhibitors to target a common oncogenic mechanism
|
5R01CA205153-02
|
$654,869
|
|
LU, KUN PING
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-08
|
$457,619
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Regulation of the LIN28/let-7 pathway in cancer
|
5R01CA211328-02
|
$404,888
|
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor
|
5R01CA211646-02
|
$411,481
|
|
ZETTER, BRUCE
|
BOSTON CHILDREN'S HOSPITAL
|
|
Characterization of Thyroid Nodules by Quantitative Ultrasound
|
5R21CA212744-02
|
$190,102
|
|
LEE, STEPHANIE
|
BOSTON MEDICAL CENTER
|
|
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
|
5R01CA208599-02
|
$603,464
|
|
GODFREY, TONY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
How does malignancy subvert platelet and megakaryocytic biology?
|
5R01CA200748-02
|
$550,945
|
|
ITALIANO, JOSEPH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
|
5R01CA203636-02
|
$567,838
|
|
NISHINO, MIZUKI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
|
5R01CA207982-02
|
$393,195
|
|
WIDLUND, HANS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
5R21CA214102-02
|
$154,969
|
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
5R21CA214102-02
|
$154,969
|
$154,969
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Diet-Associated Gut Microbiome Signatures and Risk of Colon Adenoma
|
5R03CA212558-02
|
$79,250
|
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
|
5R35CA197442-02
|
$951,000
|
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Functional Effects of Ovarian Cancer Risk Variants
|
5R01CA211707-02
|
$622,079
|
|
GAYTHER, SIMON
|
CEDARS-SINAI MEDICAL CENTER
|
|
Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC)
|
5R01CA204158-02
|
$463,965
|
|
MAYTIN, EDWARD
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Serotonin drives cancer stem cell maintenance and glioblastoma progression
|
5F32CA213727-02
|
$32,579
|
$32,579
|
SILVER, DANIEL
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Role of MIF in myeloma bone homing and drug response
|
5R01CA211073-02
|
$362,569
|
|
YI, QING
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
LMAN1 mutations in colorectal cancer development
|
5R03CA202131-02
|
$79,250
|
|
ZHANG, BIN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Exercise, Breast Cancer Prevention and Mechanisms
|
5R01CA100693-13
|
$247,214
|
|
THOMPSON, HENRY
|
COLORADO STATE UNIVERSITY
|
|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-04
|
$366,000
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CONSTRUCTION AND ANALYSIS OF RETROVIRUS MUTANTS
|
5R01CA030488-38
|
$215,354
|
|
GOFF, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Elucidating genetics of response to immune checkpoint blockade in lung cancer
|
5R01CA205426-02
|
$558,644
|
|
RIZVI, NAIYER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Hepatic Stellate Cells and Liver Cancer
|
5R01CA190844-04
|
$356,751
|
|
SCHWABE, ROBERT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Structure and function of Transient Receptor Potential channels
|
5R01CA206573-02
|
$403,563
|
|
SOBOLEVSKY, ALEXANDER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Development of molecular probes to investigate and drug the oncogenic Wnt/?-catenin/BCL9/B9L transcriptional complex
|
1R21CA221683-01
|
$229,576
|
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
|
5R01CA166480-07
|
$636,708
|
|
KUFE, DONALD
|
DANA-FARBER CANCER INST
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
5R01CA136512-08
|
$515,452
|
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
Polyploidy, aneuploidy, and genome stability
|
5R01CA213404-20
|
$400,313
|
|
PELLMAN, DAVID
|
DANA-FARBER CANCER INST
|
|
Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India
|
5R01CA200691-02
|
$579,207
|
|
SORENSEN, GLORIAN
|
DANA-FARBER CANCER INST
|
|
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
|
5R01CA204915-02
|
$396,547
|
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA023108-39
|
$3,139,824
|
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Role of septins in cytokinetic abscission
|
5F31CA213776-02
|
$44,524
|
|
KARASMANIS, EVA
|
DREXEL UNIVERSITY
|
|
Mobile contingency management for smoking cessation in returning US Veterans
|
5R01CA196304-04
|
$327,035
|
|
CALHOUN, PATRICK
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-44
|
$5,679,062
|
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Defining the Rules of Breast Cancer Cell Traffic Through Bone
|
5R01CA197848-02
|
$380,691
|
|
SIPKINS, DOROTHY
|
DUKE UNIVERSITY
|
|
Advanced a/LCI systems for improved clinical utility
|
5R01CA210544-02
|
$488,713
|
|
WAX, ADAM
|
DUKE UNIVERSITY
|
|
Modulation of BAK in Lung Cancer Therapeutics
|
5R01CA200905-02
|
$356,850
|
|
DENG, XINGMING
|
EMORY UNIVERSITY
|
|
Defining Early Escape Strategies in LKB1 Mutant Lung Cancer
|
5R01CA201340-03
|
$355,821
|
|
MARCUS, ADAM
|
EMORY UNIVERSITY
|
Total relevant funding to Depression Research for this search: $22,161,878
|